/PRNewswire/ SpliceBio, a biotechnology company exploiting protein splicing to develop next generation gene therapies, today announced the completion of an.
/PRNewswire/ SpliceBio, a biotechnology company exploiting protein splicing to develop next generation gene therapies, today announced the completion of an.
SpliceBio Raises $57 Million to Advance Protein Splicing Platform and Expand Gene Therapy Pipeline globalgenes.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globalgenes.org Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ Sorriso Pharmaceuticals, a company focused on transforming anti-inflammatory antibody therapy, today announced the company has closed on a $31.